Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02543060 · ClinicalTrials.gov registry record · NA

A Pilot Study to Evaluate a Method for Plaque When Comparing Stannous Fluoride Toothpaste to a Regular Dentifrice

A NA study of Gingivitis and Plaque, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02543060 is a NA study of Gingivitis and Plaque that has completed, run by Procter and Gamble. The registered enrollment target is 60 participants, below the 234-participant average among 25 other Gingivitis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02543060, a NA study of Gingivitis and Plaque, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the sensitivity of an assay and its ability to split a marketed stannous fluoride toothpaste versus a negative control.

Conditions Studied

Interventions

  • DRUG stannous fluoride toothpaste
  • DRUG cavity protection toothpaste

Study Locations (1)

Indiana

  • Salus Research - Fort Wayne

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-06
Est. Completion 2015-08
Phase NA

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT02543060

The ClinicalTrials.gov registry entry for NCT02543060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 234-participant average among 25 other Gingivitis trials with a reported enrollment target (74% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which stannous fluoride toothpaste is the first listed.

NCT02543060 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02543060 about?

NCT02543060 is a clinical study titled "A Pilot Study to Evaluate a Method for Plaque When Comparing Stannous Fluoride Toothpaste to a Regular Dentifrice". This study will evaluate the sensitivity of an assay and its ability to split a marketed stannous fluoride toothpaste versus a negative control.

What is the current status of trial NCT02543060?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-06. Estimated completion is 2015-08.

What conditions does trial NCT02543060 study?

This clinical trial studies the following conditions: Gingivitis, Plaque.

What interventions are being tested in trial NCT02543060?

The interventions under investigation include: stannous fluoride toothpaste (DRUG), cavity protection toothpaste (DRUG).

Who is sponsoring clinical trial NCT02543060?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02543060 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.